Testing a new imaging system for nuclear medicine scans
This study tests a new camera (StarGuide NextGen SPECT/CT) that takes 3D pictures of your body after you receive a radioactive tracer. It may help doctors see disease more clearly during your scheduled nuclear medicine test or treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have a nuclear medicine imaging test or treatment that uses a radioactive drug.
- You can lie flat on your back on a scanning bed for the procedure.
- You are not pregnant.
- You are able to give your own permission to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether having an extra SPECT/CT scan provides clearer images. If you already need a SPECT/CT scan, you may be able to join, and the extra scan might help improve imaging technology.
This study compares two types of scanning cameras to see how well they record images in people with thyroid cancer treated with iodine 131. It may help improve which camera gives clearer results after this treatment.
This study tests whether a specialized nuclear imaging camera can better detect multiple tumors or lesions in your body. You'll receive a standard radioactive tracer scan (like a bone scan or thyroid scan) that's already part of your care, but we'll also image you with this newer camera technology to see if it works well.
This trial is testing a new 3D imaging technology during a routine CT scan. It may help improve how doctors see and plan for your care, and it does not require any extra procedures or dyes.
This study tests a new X-ray system that looks at CT scans of the chest, belly, and pelvis. The goal is to see how well it works in real hospital use for adults.
This trial tests a special camera (VERITON-CT) to help guide precise radiation for bone tumors that have spread from prostate cancer. It may improve targeting accuracy during treatment.
Hear when a new Nuclear Medicine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.